SIGMA HEALTHCARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.295 AUD | -1.15% |
|
+0.39% | +28.86% |
| Mar. 25 | Miners, healthcare firms push Australia stocks higher | RE |
| Mar. 21 | Morgans Financial Downgrades Sigma Healthcare to Hold From Add; Price Target is AU$1.14 | MT |
| Sales 2025 * | 6.39B 4.17B | Sales 2026 * | 6.83B 4.45B | Capitalization | 2.03B 1.33B |
|---|---|---|---|---|---|
| Net income 2025 * | 485M 316M | Net income 2026 * | 573M 373M | EV / Sales 2025 * | 0.4 x |
| Net Debt 2025 * | 522M 340M | Net Debt 2026 * | 544M 354M | EV / Sales 2026 * | 0.38 x |
| P/E ratio 2025 * |
30.8
x | P/E ratio 2026 * |
25.9
x | Employees | 1,900 |
| Yield 2025 * |
2.32% | Yield 2026 * |
3.09% | Free-Float | 91.24% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sigma Healthcare Limited
More recommendations
| 1 day | -1.15% | ||
| 1 week | +0.39% | ||
| 1 month | +7.92% | ||
| 3 months | +33.51% | ||
| 6 months | +93.28% | ||
| Current year | +28.86% |
1 week
1.25
1.34
1 month
1.171.34
Current year
0.911.34
1 year
0.631.35
3 years
0.431.35
5 years
0.431.35
10 years
0.411.53
| Managers | Title | Age | Since |
|---|---|---|---|
Vikesh Ramsunder
CEO | Chief Executive Officer | 53 | 22-01-31 |
Mark Conway
DFI | Director of Finance/CFO | - | Oct. 31 |
Martin Hawkins
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chris Roberts
BRD | Director/Board Member | 70 | 23-10-05 |
Kathryn Spargo
BRD | Director/Board Member | 72 | 15-12-08 |
Michael Sammells
CHM | Chairman | - | 20-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 1.295 | -1.15% | 7,206,738 |
| 24-04-23 | 1.31 | +0.77% | 3,511,589 |
| 24-04-22 | 1.3 | +3.59% | 5,779,890 |
| 24-04-19 | 1.255 | -1.57% | 4,176,177 |
| 24-04-18 | 1.275 | -1.16% | 3,116,826 |
Delayed Quote Australian S.E., April 24, 2024 at 02:10 am EDT
More quotes
Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal, Guardian, and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.
Sector
Pharmaceuticals
Calendar
2024-05-30
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
1.295
AUD
Average target price
1.118
AUD
Spread / Average Target
-13.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +28.86% | 1.32B | |
| +15.65% | 70.36B | |
| +2.72% | 25.18B | |
| +5.62% | 8.61B | |
| +6.10% | 8.14B | |
| -21.85% | 7.83B | |
| +0.73% | 4.56B | |
| +17.40% | 4.32B | |
| -0.14% | 4.06B | |
| -2.34% | 3.87B |
- Stock Market
- Equities
- SIG Stock
